Abstract
Teduglutide, a glucagon-like peptide 2 analogue, might restore intestinal structural and functional integrity by promoting growth of the mucosa and reducing gastric emptying and secretion. These factors could increase fluid and nutrient absorption in patients with short bowel syndrome with intestinal failure (SBS-IF). We performed a prospective study to determine whether teduglutide reduces parenteral support in patients with SBS-IF.
| Original language | English |
|---|---|
| Journal | Gastroenterology |
| Volume | 143 |
| Issue number | 6 |
| Pages (from-to) | 1473-1481.e3 |
| Number of pages | 9 |
| ISSN | 0016-5085 |
| DOIs | |
| Publication status | Published - 2012 |
Fingerprint
Dive into the research topics of 'Teduglutide reduces need for parenteral support among patients with short bowel syndrome with intestinal failure'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS